Catalyst Pharmaceuticals, Inc. revenue for the last year amounted to 396.50 M USD, the most of which — 398.20 M USD — came from its highest performing source at the moment, Drug Products, the year earlier bringing 214.20 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Catalyst Pharmaceuticals, Inc. 398.20 M USD, and the year before that — 214.20 M USD.